FULL TEST BANK
PHARMACOLOGY FOR CANADIAN HEALTH CARE PRACTICE
3RD EDITION
BY LINDA LANE LILLEY; SNYDER; COLLINS; SWART;
SEALOCK; SENEVIRATNE CHAPTER 1-58
,TABLE OF CONTENTS
CHAPTER 01: NURSING PRACTICE IN CANADA AND DRUG THERAPY ........................................................ 4
CHAPTER 02: PHARMACOLOGICAL PRINCIPLES .......................................................................................... 9
CHAPTER 03: LEGAL AND ETHICAL CONSIDERATIONS .............................................................................. 14
CHAPTER 04: PATIENT FOCUSED CONSIDERATIONS ................................................................................. 19
CHAPTER 05: GENE THERAPY AND PHARMACOGENOMICS ..................................................................... 27
CHAPTER 06: MEDICATION ERRORS: PREVENTING AND RESPONDING ................................................... 30
CHAPTER 07: PATIENT EDUCATION AND DRUG THERAPY ........................................................................ 33
CHAPTER 08: OVER-THE-COUNTER DRUGS AND NATURAL HEALTH PRODUCTS ..................................... 38
CHAPTER 09: VITAMINS AND MINERALS ................................................................................................... 42
CHAPTER 10: PRINCIPLES OF DRUG ADMINISTRATION ............................................................................ 46
CHAPTER 11: ANALGESIC DRUGS ............................................................................................................... 55
CHAPTER 12: GENERAL AND LOCAL ANAESTHETICS ................................................................................. 62
CHAPTER 13: CENTRAL NERVOUS SYSTEM DEPRESSANTS AND MUSCLE RELAXANTS ............................ 67
CHAPTER 14: CENTRAL NERVOUS SYSTEM STIMULANTS AND RELATED DRUGS..................................... 72
CHAPTER 15: ANTIEPILEPTIC DRUGS ......................................................................................................... 78
CHAPTER 16: ANTIPARKINSONIAN DRUGS ............................................................................................... 83
CHAPTER 17: PSYCHOTHERAPEUTIC DRUGS ............................................................................................. 87
CHAPTER 18: SUBSTANCE MISUSE ............................................................................................................. 94
CHAPTER 19: ADRENERGIC DRUGS ............................................................................................................ 99
CHAPTER 20: ADRENERGIC-BLOCKING DRUGS ....................................................................................... 105
CHAPTER 21: CHOLINERGIC DRUGS ......................................................................................................... 110
CHAPTER 22: CHOLINERGIC-BLOCKING DRUGS....................................................................................... 115
CHAPTER 23: ANTIHYPERTENSIVE DRUGS ............................................................................................... 121
CHAPTER 24: ANTIANGINAL DRUGS ........................................................................................................ 126
CHAPTER 25: HEART FAILURE DRUGS ...................................................................................................... 132
CHAPTER 26: ANTIDYSRHYTHMIC DRUGS ............................................................................................... 137
CHAPTER 28: ANTILIPEMIC DRUGS .......................................................................................................... 148
CHAPTER 29: DIURETIC DRUGS ................................................................................................................ 154
CHAPTER 30: FLUIDS AND ELECTROLYTES ............................................................................................... 160
,CHAPTER 31: PITUITARY DRUGS .............................................................................................................. 165
CHAPTER 32: THYROID AND ANTITHYROID DRUGS ................................................................................ 169
CHAPTER 33: ANTIDIABETIC DRUGS ........................................................................................................ 174
CHAPTER 34: ADRENAL DRUGS................................................................................................................ 181
CHAPTER 35: WOMEN’S HEALTH DRUGS ................................................................................................ 185
CHAPTER 36: MEN’S HEALTH DRUGS....................................................................................................... 192
CHAPTER 37: ANTIHISTAMINES, DECONGESTANTS, ANTITUSSIVES, AND EXPECTORANTS .................. 197
CHAPTER 38: RESPIRATORY DRUGS......................................................................................................... 202
CHAPTER 39: ACID-CONTROLLING DRUGS .............................................................................................. 208
CHAPTER 40: ANTIDIARRHEAL DRUGS AND LAXATIVES ......................................................................... 213
CHAPTER 41: ANTIEMETIC AND ANTI-NAUSEA DRUGS .......................................................................... 219
CHAPTER 42: NUTRITIONAL SUPPLEMENTS ............................................................................................ 223
CHAPTER 43: ANTIBIOTICS, PART 1: SULFONAMIDES, PENICILLINS, CEPHALOSPORINS, MACROLIDES,
AND TETRACYCLINES ................................................................................................................................ 227
CHAPTER 44: ANTIBIOTICS PART 2: AMINOGLYCOSIDES, FLUOROQUINOLONES, AND OTHER DRUGS232
CHAPTER 45: ANTIVIRAL DRUGS.............................................................................................................. 236
CHAPTER 46: ANTITUBERCULAR DRUGS ................................................................................................. 242
CHAPTER 47: ANTIFUNGAL DRUGS .......................................................................................................... 247
CHAPTER 48: ANTIMALARIAL, ANTIPROTOZOAL, AND ANTHELMINTIC DRUGS .................................... 252
CHAPTER 49: ANTI-INFLAMMATORY AND ANTIGOUT DRUGS ............................................................... 256
CHAPTER 50: IMMUNOSUPPRESSANT DRUGS ........................................................................................ 262
CHAPTER 51: IMMUNIZING DRUGS AND PANDEMIC PREPAREDNESS ................................................... 265
CHAPTER 52: ANTINEOPLASTIC DRUGS PART 1: CANCER OVERVIEW AND CELL CYCLE–SPECIFIC DRUGS
.................................................................................................................................................................. 271
CHAPTER 53: ANTINEOPLASTIC DRUGS PART 2: CELL CYCLE–NONSPECIFIC AND MISCELLANEOUS
DRUGS....................................................................................................................................................... 275
CHAPTER 54: BIOLOGICAL RESPONSE–MODIFYING DRUGS ................................................................... 278
CHAPTER 55: ANEMIA DRUGS.................................................................................................................. 282
CHAPTER 56: DERMATOLOGICAL DRUGS ................................................................................................ 287
CHAPTER 57: OPHTHALMIC DRUGS ......................................................................................................... 292
CHAPTER 58: OTIC DRUGS........................................................................................................................ 296
, CHAPTER 01: NURSING PRACTICE IN CANADA AND DRUG THERAPY
LILLEY: PHARMACOLOGY FOR CANADIAN HEALTH CARE PRACTICE, 3RD CANADIAN EDITION
MULTIPLE CHOICE
1. WHICH IS A JUDGEMENT ABOUT A PARTICULAR PATIENT‘S POTENTIAL NEED OR PROBLEM?
A. A GOAL
B. AN ASSESSMENT
C. SUBJECTIVE DATA
D. A NURSING DIAGNOSIS
CORRECT ANSWER>> D
NURSING DIAGNOSIS IS THE PHASE OF THE NURSING PROCESS DURING WHICH A CLINICAL JUDGEMENT
IS MADE ABOUT HOW A PATIENT RESPONDS TO HEATH CONDITIONS AND LIFE PROCESSES OR
VULNERABILITY FOR THAT RESPONSE.
DIF: COGNITIVE LEVEL: KNOWLEDGE REF: P. 11
2. THE PATIENT IS TO RECEIVE ORAL FUROSEMIDE (LASIX) EVERY DAY; HOWEVER, BECAUSE THE
PATIENT IS UNABLE TO SWALLOW, HE CANNOT TAKE MEDICATION ORALLY, AS ORDERED. THE NURSE
NEEDS TO CONTACT THE PHYSICIAN. WHAT TYPE OF PROBLEM IS THIS?
A. A ―RIGHT TIME‖ PROBLEM
B. A ―RIGHT DOSE‖ PROBLEM
C. A ―RIGHT ROUTE‖ PROBLEM
D. A ―RIGHT MEDICATION‖ PROBLEM
CORRECT ANSWER>> C
THIS IS A ―RIGHT ROUTE‖ PROBLEM: THE NURSE CANNOT ASSUME THE ROUTE AND MUST CLARIFY THE
ROUTE
WITH THE PRESCRIBER. THIS IS NOT A ―RIGHT TIME‖ PROBLEM BECAUSE THE ORDERED FREQUENCY
HAS NOT CHANGED. THIS IS NOT A ―RIGHT DOSE‖ PROBLEM BECAUSE THE DOSE IS NOT RELATED TO
AN INABILITY TO SWALLOW. THIS IS NOT A ―RIGHT MEDICATION‖ PROBLEM BECAUSE THE
MEDICATION ORDERED WILL NOT CHANGE, JUST THE ROUTE.
DIF: COGNITIVE LEVEL: APPLICATIONREF: P. 14
PHARMACOLOGY FOR CANADIAN HEALTH CARE PRACTICE
3RD EDITION
BY LINDA LANE LILLEY; SNYDER; COLLINS; SWART;
SEALOCK; SENEVIRATNE CHAPTER 1-58
,TABLE OF CONTENTS
CHAPTER 01: NURSING PRACTICE IN CANADA AND DRUG THERAPY ........................................................ 4
CHAPTER 02: PHARMACOLOGICAL PRINCIPLES .......................................................................................... 9
CHAPTER 03: LEGAL AND ETHICAL CONSIDERATIONS .............................................................................. 14
CHAPTER 04: PATIENT FOCUSED CONSIDERATIONS ................................................................................. 19
CHAPTER 05: GENE THERAPY AND PHARMACOGENOMICS ..................................................................... 27
CHAPTER 06: MEDICATION ERRORS: PREVENTING AND RESPONDING ................................................... 30
CHAPTER 07: PATIENT EDUCATION AND DRUG THERAPY ........................................................................ 33
CHAPTER 08: OVER-THE-COUNTER DRUGS AND NATURAL HEALTH PRODUCTS ..................................... 38
CHAPTER 09: VITAMINS AND MINERALS ................................................................................................... 42
CHAPTER 10: PRINCIPLES OF DRUG ADMINISTRATION ............................................................................ 46
CHAPTER 11: ANALGESIC DRUGS ............................................................................................................... 55
CHAPTER 12: GENERAL AND LOCAL ANAESTHETICS ................................................................................. 62
CHAPTER 13: CENTRAL NERVOUS SYSTEM DEPRESSANTS AND MUSCLE RELAXANTS ............................ 67
CHAPTER 14: CENTRAL NERVOUS SYSTEM STIMULANTS AND RELATED DRUGS..................................... 72
CHAPTER 15: ANTIEPILEPTIC DRUGS ......................................................................................................... 78
CHAPTER 16: ANTIPARKINSONIAN DRUGS ............................................................................................... 83
CHAPTER 17: PSYCHOTHERAPEUTIC DRUGS ............................................................................................. 87
CHAPTER 18: SUBSTANCE MISUSE ............................................................................................................. 94
CHAPTER 19: ADRENERGIC DRUGS ............................................................................................................ 99
CHAPTER 20: ADRENERGIC-BLOCKING DRUGS ....................................................................................... 105
CHAPTER 21: CHOLINERGIC DRUGS ......................................................................................................... 110
CHAPTER 22: CHOLINERGIC-BLOCKING DRUGS....................................................................................... 115
CHAPTER 23: ANTIHYPERTENSIVE DRUGS ............................................................................................... 121
CHAPTER 24: ANTIANGINAL DRUGS ........................................................................................................ 126
CHAPTER 25: HEART FAILURE DRUGS ...................................................................................................... 132
CHAPTER 26: ANTIDYSRHYTHMIC DRUGS ............................................................................................... 137
CHAPTER 28: ANTILIPEMIC DRUGS .......................................................................................................... 148
CHAPTER 29: DIURETIC DRUGS ................................................................................................................ 154
CHAPTER 30: FLUIDS AND ELECTROLYTES ............................................................................................... 160
,CHAPTER 31: PITUITARY DRUGS .............................................................................................................. 165
CHAPTER 32: THYROID AND ANTITHYROID DRUGS ................................................................................ 169
CHAPTER 33: ANTIDIABETIC DRUGS ........................................................................................................ 174
CHAPTER 34: ADRENAL DRUGS................................................................................................................ 181
CHAPTER 35: WOMEN’S HEALTH DRUGS ................................................................................................ 185
CHAPTER 36: MEN’S HEALTH DRUGS....................................................................................................... 192
CHAPTER 37: ANTIHISTAMINES, DECONGESTANTS, ANTITUSSIVES, AND EXPECTORANTS .................. 197
CHAPTER 38: RESPIRATORY DRUGS......................................................................................................... 202
CHAPTER 39: ACID-CONTROLLING DRUGS .............................................................................................. 208
CHAPTER 40: ANTIDIARRHEAL DRUGS AND LAXATIVES ......................................................................... 213
CHAPTER 41: ANTIEMETIC AND ANTI-NAUSEA DRUGS .......................................................................... 219
CHAPTER 42: NUTRITIONAL SUPPLEMENTS ............................................................................................ 223
CHAPTER 43: ANTIBIOTICS, PART 1: SULFONAMIDES, PENICILLINS, CEPHALOSPORINS, MACROLIDES,
AND TETRACYCLINES ................................................................................................................................ 227
CHAPTER 44: ANTIBIOTICS PART 2: AMINOGLYCOSIDES, FLUOROQUINOLONES, AND OTHER DRUGS232
CHAPTER 45: ANTIVIRAL DRUGS.............................................................................................................. 236
CHAPTER 46: ANTITUBERCULAR DRUGS ................................................................................................. 242
CHAPTER 47: ANTIFUNGAL DRUGS .......................................................................................................... 247
CHAPTER 48: ANTIMALARIAL, ANTIPROTOZOAL, AND ANTHELMINTIC DRUGS .................................... 252
CHAPTER 49: ANTI-INFLAMMATORY AND ANTIGOUT DRUGS ............................................................... 256
CHAPTER 50: IMMUNOSUPPRESSANT DRUGS ........................................................................................ 262
CHAPTER 51: IMMUNIZING DRUGS AND PANDEMIC PREPAREDNESS ................................................... 265
CHAPTER 52: ANTINEOPLASTIC DRUGS PART 1: CANCER OVERVIEW AND CELL CYCLE–SPECIFIC DRUGS
.................................................................................................................................................................. 271
CHAPTER 53: ANTINEOPLASTIC DRUGS PART 2: CELL CYCLE–NONSPECIFIC AND MISCELLANEOUS
DRUGS....................................................................................................................................................... 275
CHAPTER 54: BIOLOGICAL RESPONSE–MODIFYING DRUGS ................................................................... 278
CHAPTER 55: ANEMIA DRUGS.................................................................................................................. 282
CHAPTER 56: DERMATOLOGICAL DRUGS ................................................................................................ 287
CHAPTER 57: OPHTHALMIC DRUGS ......................................................................................................... 292
CHAPTER 58: OTIC DRUGS........................................................................................................................ 296
, CHAPTER 01: NURSING PRACTICE IN CANADA AND DRUG THERAPY
LILLEY: PHARMACOLOGY FOR CANADIAN HEALTH CARE PRACTICE, 3RD CANADIAN EDITION
MULTIPLE CHOICE
1. WHICH IS A JUDGEMENT ABOUT A PARTICULAR PATIENT‘S POTENTIAL NEED OR PROBLEM?
A. A GOAL
B. AN ASSESSMENT
C. SUBJECTIVE DATA
D. A NURSING DIAGNOSIS
CORRECT ANSWER>> D
NURSING DIAGNOSIS IS THE PHASE OF THE NURSING PROCESS DURING WHICH A CLINICAL JUDGEMENT
IS MADE ABOUT HOW A PATIENT RESPONDS TO HEATH CONDITIONS AND LIFE PROCESSES OR
VULNERABILITY FOR THAT RESPONSE.
DIF: COGNITIVE LEVEL: KNOWLEDGE REF: P. 11
2. THE PATIENT IS TO RECEIVE ORAL FUROSEMIDE (LASIX) EVERY DAY; HOWEVER, BECAUSE THE
PATIENT IS UNABLE TO SWALLOW, HE CANNOT TAKE MEDICATION ORALLY, AS ORDERED. THE NURSE
NEEDS TO CONTACT THE PHYSICIAN. WHAT TYPE OF PROBLEM IS THIS?
A. A ―RIGHT TIME‖ PROBLEM
B. A ―RIGHT DOSE‖ PROBLEM
C. A ―RIGHT ROUTE‖ PROBLEM
D. A ―RIGHT MEDICATION‖ PROBLEM
CORRECT ANSWER>> C
THIS IS A ―RIGHT ROUTE‖ PROBLEM: THE NURSE CANNOT ASSUME THE ROUTE AND MUST CLARIFY THE
ROUTE
WITH THE PRESCRIBER. THIS IS NOT A ―RIGHT TIME‖ PROBLEM BECAUSE THE ORDERED FREQUENCY
HAS NOT CHANGED. THIS IS NOT A ―RIGHT DOSE‖ PROBLEM BECAUSE THE DOSE IS NOT RELATED TO
AN INABILITY TO SWALLOW. THIS IS NOT A ―RIGHT MEDICATION‖ PROBLEM BECAUSE THE
MEDICATION ORDERED WILL NOT CHANGE, JUST THE ROUTE.
DIF: COGNITIVE LEVEL: APPLICATIONREF: P. 14
